Management of macular edema secondary to branch retinal vein occlusion: An evidence-based update

Ahmad A. Aref, Ingrid Scott

Research output: Contribution to journalReview article

18 Citations (Scopus)

Abstract

Retinal vein occlusions are common retinal vascular disorders with the potential for significant vision-related morbidity. Retinal vein occlusions are classified as either branch retinal vein occlusion (BRVO), central retinal vein occlusion (CRVO), or hemiretinal vein occlusion (HRVO) based on the specific occlusion site. The most common cause of decreased vision in patients afflicted with BRVO is the accumulation of fluid within the macula (macular edema). The Branch Vein Occlusion Study (BVOS) demonstrated the efficacy of grid laser photocoagulation in the treatment of BRVO-related macular edema. After publication of that report, grid laser became the standard of care for decreased vision due to BRVO-associated macular edema in patients similar to those enrolled in the BVOS. However, several recent major randomized, controlled clinical trials have investigated new therapeutic modalities for the treatment of decreased vision due to macular edema secondary to BRVO. This article aims to provide insight into current evidence-based approaches to management of macular edema secondary to BRVO. A companion article reviews approaches for management of macular edema secondary to CRVO.

Original languageEnglish (US)
Pages (from-to)28-39
Number of pages12
JournalAdvances in Therapy
Volume28
Issue number1
DOIs
StatePublished - Jan 1 2011

Fingerprint

Retinal Vein Occlusion
Macular Edema
Retinal Vein
Veins
Lasers
Retinal Vessels
Light Coagulation
Standard of Care
Publications
Therapeutics
Randomized Controlled Trials
Morbidity

All Science Journal Classification (ASJC) codes

  • Medicine(all)
  • Pharmacology (medical)

Cite this

@article{e92073980ac44e54976088524e2ff2f9,
title = "Management of macular edema secondary to branch retinal vein occlusion: An evidence-based update",
abstract = "Retinal vein occlusions are common retinal vascular disorders with the potential for significant vision-related morbidity. Retinal vein occlusions are classified as either branch retinal vein occlusion (BRVO), central retinal vein occlusion (CRVO), or hemiretinal vein occlusion (HRVO) based on the specific occlusion site. The most common cause of decreased vision in patients afflicted with BRVO is the accumulation of fluid within the macula (macular edema). The Branch Vein Occlusion Study (BVOS) demonstrated the efficacy of grid laser photocoagulation in the treatment of BRVO-related macular edema. After publication of that report, grid laser became the standard of care for decreased vision due to BRVO-associated macular edema in patients similar to those enrolled in the BVOS. However, several recent major randomized, controlled clinical trials have investigated new therapeutic modalities for the treatment of decreased vision due to macular edema secondary to BRVO. This article aims to provide insight into current evidence-based approaches to management of macular edema secondary to BRVO. A companion article reviews approaches for management of macular edema secondary to CRVO.",
author = "Aref, {Ahmad A.} and Ingrid Scott",
year = "2011",
month = "1",
day = "1",
doi = "10.1007/s12325-010-0089-3",
language = "English (US)",
volume = "28",
pages = "28--39",
journal = "Advances in Therapy",
issn = "0741-238X",
publisher = "Health Communications Inc.",
number = "1",

}

Management of macular edema secondary to branch retinal vein occlusion : An evidence-based update. / Aref, Ahmad A.; Scott, Ingrid.

In: Advances in Therapy, Vol. 28, No. 1, 01.01.2011, p. 28-39.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Management of macular edema secondary to branch retinal vein occlusion

T2 - An evidence-based update

AU - Aref, Ahmad A.

AU - Scott, Ingrid

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Retinal vein occlusions are common retinal vascular disorders with the potential for significant vision-related morbidity. Retinal vein occlusions are classified as either branch retinal vein occlusion (BRVO), central retinal vein occlusion (CRVO), or hemiretinal vein occlusion (HRVO) based on the specific occlusion site. The most common cause of decreased vision in patients afflicted with BRVO is the accumulation of fluid within the macula (macular edema). The Branch Vein Occlusion Study (BVOS) demonstrated the efficacy of grid laser photocoagulation in the treatment of BRVO-related macular edema. After publication of that report, grid laser became the standard of care for decreased vision due to BRVO-associated macular edema in patients similar to those enrolled in the BVOS. However, several recent major randomized, controlled clinical trials have investigated new therapeutic modalities for the treatment of decreased vision due to macular edema secondary to BRVO. This article aims to provide insight into current evidence-based approaches to management of macular edema secondary to BRVO. A companion article reviews approaches for management of macular edema secondary to CRVO.

AB - Retinal vein occlusions are common retinal vascular disorders with the potential for significant vision-related morbidity. Retinal vein occlusions are classified as either branch retinal vein occlusion (BRVO), central retinal vein occlusion (CRVO), or hemiretinal vein occlusion (HRVO) based on the specific occlusion site. The most common cause of decreased vision in patients afflicted with BRVO is the accumulation of fluid within the macula (macular edema). The Branch Vein Occlusion Study (BVOS) demonstrated the efficacy of grid laser photocoagulation in the treatment of BRVO-related macular edema. After publication of that report, grid laser became the standard of care for decreased vision due to BRVO-associated macular edema in patients similar to those enrolled in the BVOS. However, several recent major randomized, controlled clinical trials have investigated new therapeutic modalities for the treatment of decreased vision due to macular edema secondary to BRVO. This article aims to provide insight into current evidence-based approaches to management of macular edema secondary to BRVO. A companion article reviews approaches for management of macular edema secondary to CRVO.

UR - http://www.scopus.com/inward/record.url?scp=79952537493&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952537493&partnerID=8YFLogxK

U2 - 10.1007/s12325-010-0089-3

DO - 10.1007/s12325-010-0089-3

M3 - Review article

C2 - 21153509

AN - SCOPUS:79952537493

VL - 28

SP - 28

EP - 39

JO - Advances in Therapy

JF - Advances in Therapy

SN - 0741-238X

IS - 1

ER -